Company/Organization Disease Area Total None Applicable Cardiovascular Neurological Dermatology Otorhinolaryngological Gastrointestinal Genetic Genitourinary and Sex Hormones Blood Hormone Immunology Infections Women's Health Metabolic Oral and Dental Musculoskeletal Nutritional Oncology Ophthalmic Others Respiratory Undisclosed Multidisciplinary Indication Global Clinical Stage New Drug Type Total None Applicable Incrementally Modified Drug Other New Drug Bio New Drug New Molecular Entity Subtype Total None Applicable Biologic Cell Therapy Gene Therapy Registration Month Development Stage Leading and Candidate Preclinical Trials Phase 1 Clinical Trials Phase 2 Clinical Trials Phase 3 Clinical Trials Licensing
